Currently out of the existing stock ratings of Kevin Caliendo, 194 are a BUY (49.36%), 14 are a SELL (3.56%), 185 are a HOLD (47.07%).

Kevin Caliendo

Work Performance Price Targets & Ratings Chart

Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 68.94% that have a potential upside of 18.73% achieved within 243 days.

Kevin Caliendo’s has documented 767 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on CAH, Cardinal Health at 12-Aug-2026.

Wall Street Analyst Kevin Caliendo

Analyst best performing recommendations are on NVST (ENVISTA HOLDINGS CORP).
The best stock recommendation documented was for CVS (CVS HEALTH CORP) at 2/10/2025. The price target of $59 was fulfilled within 2 days with a profit of $6.7 (12.81%) receiving and performance score of 64.05.

Average potential price target upside

ABC AmerisourceBergen ALGN Align Technology CAH Cardinal Health CERN Cerner Corp CI Cigna Corp CVS CVS Health Corp DGX Quest Diagnostics HSIC Henry Schein LH Laboratory of America Holdings MCK McKesson OMI Owens & Minor SDC SmileDirectClub TDOC Teladoc TEVA Teva Pharma Industries Ltd ADR UNH UnitedHealth Group WBA Walgreens Boots Alliance ALHC Alignment Healthcare LLC JNJ Johnson & Johnson LFST Lifestance Health Group SGFY Signify Health DPLO Diplomat Pharmacy XRAY Dentsply Sirona ELV Elevance Health HUM Humana PINC Premier AGTI Agiliti AHCO Adapthealth Corp AMWL American Well Corp PDCO Patterson Companies MOH Molina Healthcare CNC Centene Corp EVH Evolent Health GDRX Goodrx Holdings  COR Cencora NVST Envista Holdings Corp ANTM Anthem SOLV Solventum Corp. WB Weibo Corp ZIMV ZimVie SG Sweetgreen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Feb-2018

$215

$40.04 (22.89%)

$187

Hold Since 27-May-2022

$190

$15.04 (8.60%)

$176

Buy Since 11-Oct-2022

$215

$40.04 (22.89%)

$200

Buy Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

Show more analysts

Please expand the browser size to see the chart

Which stock is Kevin Caliendo is most bullish on?

Potential upside of $226.29 has been obtained for MCK (MCKESSON)

Which stock is Kevin Caliendo is most reserved on?

Potential downside of -$14.4 has been obtained for DGX (QUEST DIAGNOSTICS)

What Year was the first public recommendation made by Kevin Caliendo?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?